Fundraising Fox

Quellis Biosciences

Philadelphia, US · Founded 2017 · Delaware corporation · 2 known investors

Founders & leadership

FC
Fred CalloriNamed on SEC filing

Board

CG
Chris GarabedianBoard director
TK
Tomas KiselakBoard director
PH
Peter HarwinBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$12.1M disclosed across 1 of 3 rounds · 2018–2020

$1MofferedDec 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frederick CalloriDirector
  • Christopher GarabedianDirector
  • Jonathan ViolinExecutive Officer, Director
Offering amount
$1M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$12.1MraisedAug 2020 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan ViolinExecutive Officer, Director
  • Frederick CalloriDirector
  • Christopher GarabedianDirector
Offering amount
$18.5M
Amount sold
$12.1M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
Undisclosed amountofferedJun 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris GarabedianDirector
  • Fred CalloriDirector
  • Tomas KiselakExecutive Officer, Director
  • Peter HarwinExecutive Officer, Director
First sale
May 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who are Quellis Biosciences's investors?
Quellis Biosciences's investors include Perceptive Xontogeny Venture, RA Capital.
How much funding has Quellis Biosciences raised?
Quellis Biosciences has disclosed $12.1M raised across 1 of its 3 known rounds.
Where is Quellis Biosciences headquartered?
Quellis Biosciences is headquartered in Philadelphia, US.